SCHEMBL17009647

SCHEMBL17009647

CCCC[C@@H](C)NCc1c[nH]c2c(N)ncnc12

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MTAP Q13126 18/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17009970 0.96 MTAP (0.56) MTAP
SCHEMBL17009685 0.95 MTAP (0.55) MTAP
SCHEMBL17009752 0.93 MTAP (0.59) MTAP
SCHEMBL22212762 0.85 MTAP (0.72) MTAP
SCHEMBL17019924 0.85 MTAP (0.72) MTAP
SCHEMBL17009657 0.85 MTAP (0.72) MTAP
SCHEMBL17009803 0.84 MTAP (0.65) MTAP
SCHEMBL17009940 0.84 MTAP (0.70) MTAP
SCHEMBL17009644 0.83 MTAP (0.65) MTAP
SCHEMBL22204046 0.81 MTAP (0.69) MTAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3104707-A1 TREATMENT OF H. PYLORI INFECTIONS USING MTAN INHIBITORS Albert Einstein College of Medicine, Inc. (US) 2016-12-21 — — EP disclosed
WO-2015123101-A1 TREATMENT OF H. PYLORI INFECTIONS USING MTAN INHIBITORS ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2015-08-20 — — WO disclosed
Send feedback